Liver Transplantation in Primary Hyperoxaluria: A Single‐Center 10‐Year Experience
PHs is a rare metabolic disorder, and LT significantly improves both survival and quality of life for affected patients. In our cohort, the majority of patients exhibited favorable long-term outcomes, along with a notable reduction in urine oxalate levels post-transplantation. However, challenges persist, including graft shortages and the risk of renal graft loss due to oxalosis, which continue to affect overall treatment outcomes. These findings highlight the importance of close monitoring and multidisciplinary care in managing PH patients' post-transplant.
Authors
- Zahra Beyzaei (ORCID: https://orcid.org/0000-0002-8987-2555)
- Kourosh Kazemi (ORCID: https://orcid.org/0000-0003-4477-7121)
- Alireza Shamsaeefar (ORCID: https://orcid.org/0000-0003-3798-6064)
- Saman Nikeghbalian (ORCID: https://orcid.org/0000-0003-4530-8829)
- Bita Geramizadeh (ORCID: https://orcid.org/0000-0003-1009-0049)
- Masoud Dehghani
- Ali Bahador
- S A Malek-Hosseini
- Kiana Ghatei
Institutions
- Shiraz University of Medical Sciences (IR)
- Sina Hospital (IR)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1111/petr.70102
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shiraz University of Medical Sciences